Andrew J. Goffe is 10% at NOVEN PHARMACEUTICALS INC (NOVN). They have made 7 open-market trades across 3 companies since 2008, most recently 2009-02-20.
CIK 0001430370
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $3.1M since 2008, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NOVN | SELL | 2009-02-19 | 2009-02-23 | $9.65 | $120K | +40.1% | +25.7% | +25.7% |
| NOVN | SELL | 2009-02-17 | 2009-02-19 | $9.67 | $261K | +40.1% | +25.7% | +25.7% |
| NOVN | SELL | 2009-01-29 | 2009-02-02 | $10.04 | $502K | +40.1% | +25.7% | +25.7% |
| NOVN | SELL | 2009-01-09 | 2009-01-13 | $11.00 | $88K | +40.1% | +25.7% | +25.7% |
| PrivateNOVEN PHARMACEUTICALS INC | SELL | 2008-12-29 | 2008-12-31 | $11.00 | $737 | N/A | N/A | N/A |
| NOVN | BUY | 2008-03-27 | 2008-03-31 | $9.73 | $1.1M | +40.1% | +25.7% | +25.7% |
| SMBL | BUY | 2008-03-14 | 2008-03-28 | $5.77 | $2.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.